Health·2,845 stories
Eli Lilly and the FDA allowed a single individual to receive the pharma company's experimental obesity drug retatrutide through the agency's compassionate use program, an extraordinary pre-approval ac
OpenEvidence is set to integrate an FDA-cleared AI tool that detects heart disease from EKGs, developed by researcher Pierre Elias, a 2020 STAT Wunderkind now commercializing his academic work.
Austin-based Minicircle is preparing to sell an injectable klotho gene therapy at offshore clinics in Honduras, the Bahamas, and Panama within six months — sidestepping FDA approval and rigorous clini
Digital health company Cadence raised $100 million led by Spark Capital at a $1.23 billion valuation, betting on AI automation to scale chronic disease management even as its remote-monitoring billing
Serapha Bio launched Tuesday with $230 million in total funding and a Chinese licensing deal to develop a one-and-done gene-editing treatment for Alpha-1 Antitrypsin Deficiency, a rare liver and lung
An opinion piece in STAT argues the Supreme Court's pending decision in Trump v. Barbara — which could end birthright citizenship — would deny health coverage to nearly 9% of U.S. births and weaken de
An AI model called EchoNext, which detects structural heart disease from EKG images, has received FDA clearance and is heading to the clinician search engine OpenEvidence, marking a novel distribution
Eli Lilly and the FDA allowed a 79-year-old man to access the experimental obesity drug retatrutide through the compassionate use program, with anonymous sources telling STAT the recipient was likely
Devi Sridhar pushes back against coverage of a Lancet study suggesting just five minutes of daily exercise suffices, arguing the study modeled rather than tested activity increases and that movement t
Eli Lilly plans to deploy its $7.3 billion cash reserve to fund an "App Store" for biotech scientists, following a 2025 data center launch running 1,016 Blackwell chips and AI drug-discovery collabora
Researchers in Taiwan have identified the island's tallest tree, a roughly 1,000-year-old Taiwania cryptomerioides nicknamed 'Heaven Sword of the Da'an River' that towers 84.1 metres — higher than a t
University of Colorado Anschutz researchers report that genicular artery embolization (GAE), a minimally invasive outpatient procedure, is helping chronic knee pain patients avoid total knee replaceme
A new review in Frontiers in Nutrition argues that current public health guidelines for exercise and protein are aimed at preventing deficiency rather than optimizing long-term health, and that most p
The NHS in England and Wales has approved teplizumab, the first immunotherapy drug to delay the onset of type 1 diabetes by roughly three years, with around 820 patients per year expected to benefit o
Pfizer's experimental lung cancer drug sigvotatug vedotin, acquired in the $43 billion Seagen deal, failed a clinical trial meant to position it as a replacement for the widely used chemotherapy docet
An 83-year-old woman with decade-long severe Alzheimer's began initiating conversations and regained bladder control and mobility after receiving a high dose of psilocybin, prompting both calls for cl
New research reveals menopause triggers a dramatic 'bioenergetic crisis' in the brain, but two leading scientists disagree on whether it literally cannibalizes its own white matter for fuel — a debate
The FDA announced a pilot program to accelerate early-stage clinical trials, aiming to shave 6-12 months off development timelines and reverse what officials describe as U.S. losses to China in clinic
A Russian team restored walking ability in pigs with completely severed spinal cords using a polyethylene glycol and chitosan 'fusogen,' with all three treated animals walking unsteadily within 60 day
Neuroscience has no single age for brain adulthood — different networks mature at different times, with some white matter tracts not reaching full development until the 40s, undermining the long-popul
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.